pH as a potential therapeutic target to improve temozolomide antitumor efficacy : A mechanistic modeling study
Abstract Despite intensive treatments including temozolomide (TMZ) administration, glioblastoma patient prognosis remains dismal and innovative therapeutic strategies are urgently needed. A systems pharmacology approach was undertaken to investigate TMZ pharmacokinetics‐pharmacodynamics (PK‐PD) inco...
Saved in:
Main Authors: | Angélique Stéphanou (Author), Annabelle Ballesta (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell state‐directed therapy - epigenetic modulation of gene transcription demonstrated with a quantitative systems pharmacology model of temozolomide
by: Anshul Saini, et al.
Published: (2023) -
Improved therapeutic index of an acidic pH-selective antibody
by: Peter S. Lee, et al.
Published: (2022) -
Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems
by: Johannes Andreas Blechar, et al.
Published: (2020) -
pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents
by: Erum Malik, et al.
Published: (2016) -
Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo
by: Wanfu Men, et al.
Published: (2020)